BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 28850753)

  • 1. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
    Melchor JC; Khalil A; Wing D; Schleussner E; Surbek D
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):442-451. PubMed ID: 29920825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor.
    Ravi M; Beljorie M; El Masry K
    J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3909-3914. PubMed ID: 29807458
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor.
    Nikolova T; Bayev O; Nikolova N; Di Renzo GC
    J Perinat Med; 2015 Jul; 43(4):395-402. PubMed ID: 25562603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of spontaneous preterm delivery in women presenting with premature labor: a comparison of placenta alpha microglobulin-1, phosphorylated insulin-like growth factor binding protein-1, and cervical length.
    Nikolova T; Uotila J; Nikolova N; Bolotskikh VM; Borisova VY; Di Renzo GC
    Am J Obstet Gynecol; 2018 Dec; 219(6):610.e1-610.e9. PubMed ID: 30240653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a novel placental alpha microglobulin-1 (PAMG-1) test to predict spontaneous preterm delivery.
    Nikolova T; Bayev O; Nikolova N; Di Renzo GC
    J Perinat Med; 2014 Jul; 42(4):473-7. PubMed ID: 24334429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of placental alpha microglobulin-1(PAMG1) accuracy for prediction of preterm delivery in women with the symptoms of spontaneous preterm labor; a comparison with cervical length and number of contractions.
    Kashanian M; Eshraghi N; Rahimi M; Sheikhansari N
    J Matern Fetal Neonatal Med; 2022 Feb; 35(3):534-540. PubMed ID: 32068450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effectiveness of a PAMG-1 test and standard clinical assessment in the prediction of preterm birth and reduction of unnecessary hospital admissions.
    Lotfi G; Faraz S; Nasir R; Somini S; Abdeldayem RM; Koratkar R; Alsawalhi N; Ammar A
    J Matern Fetal Neonatal Med; 2019 Mar; 32(5):793-797. PubMed ID: 29073805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
    Peláez LM; Fox NS; Chasen ST
    J Perinat Med; 2008; 36(3):202-5. PubMed ID: 18576928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New methods for preterm birth prediction: the PAMG-1 test].
    Di Fabrizio L; Giardina I; Cetin I; Di Tommaso M; Ciavattini A; Locci M; Facchinetti F; Zonca M; Di Renzo GC
    Minerva Ginecol; 2018 Oct; 70(5):635-640. PubMed ID: 29856188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of fetal fibronectin for the prediction of preterm birth in symptomatic twin pregnancies: a pilot study.
    Fuchs F; Lefevre C; Senat MV; Fernandez H
    Sci Rep; 2018 Feb; 8(1):2160. PubMed ID: 29391455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women.
    Jun SY; Lee JY; Kim HM; Kim MJ; Cha HH; Seong WJ
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):241. PubMed ID: 31296172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biochemical markers of spontaneous preterm birth in singleton and multiple pregnancies.
    Barinov SV; Di Renzo GC; Belinina AA; Koliado OV; Remneva OV
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5724-5729. PubMed ID: 33627033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study
    Levine LD; Downes KL; Romero JA; Pappas H; Elovitz MA
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3792-3800. PubMed ID: 29727248
    [No Abstract]   [Full Text] [Related]  

  • 16. Cervicovaginal fetal fibronectin (FFN) for prediction of preterm delivery in symptomatic cases: a prospective study.
    Tanir HM; Sener T; Yildiz Z
    Clin Exp Obstet Gynecol; 2008; 35(1):61-4. PubMed ID: 18390084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cervicovaginal PAMG-1 protein as a predictor of delivery within seven days in pregnancies at risk of premature birth.
    Çekmez Y; Kıran G; Haberal ET; Dizdar M
    BMC Pregnancy Childbirth; 2017 Jul; 17(1):246. PubMed ID: 28747164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental Alpha Microglobulin-1 Compared With Fetal Fibronectin to Predict Preterm Delivery in Symptomatic Women.
    Wing DA; Haeri S; Silber AC; Roth CK; Weiner CP; Echebiri NC; Franco A; Pappas LM; Yeast JD; Brebnor AA; Quirk JG; Murphy AM; Laurent LC; Field NT; Norton ME
    Obstet Gynecol; 2017 Dec; 130(6):1183-1191. PubMed ID: 29112664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, double-blinded cohort study using quantitative fetal fibronectin testing in symptomatic women for the prediction of spontaneous preterm delivery.
    Ng VWY; Seto MTY; Lewis H; Cheung KW
    BMC Pregnancy Childbirth; 2023 Apr; 23(1):225. PubMed ID: 37016314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
    Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Vandenbussche FP; Woiski MD; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvank BW; van Eyck J; Franssen MT; Sollie KM; van der Post JA; Bossuyt PM; Opmeer BC; Kok M; Mol BW; van Baaren GJ
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():220-224. PubMed ID: 27750180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.